Cote d'IvoireReagent Kits, DiagnosticRNA, ViralViral LoadHIV-1HIV InfectionsSensitivity and SpecificityReproducibility of ResultsHIV SeropositivityHIV SeroprevalenceHIV SeronegativityAIDS SerodiagnosisHIV AntigensAnti-HIV AgentsAcquired Immunodeficiency SyndromeHIV Protease InhibitorsSexual BehaviorHomosexuality, MaleCD4 Lymphocyte CountRisk-TakingAnti-Retroviral AgentsHIV Core Protein p24HIV Reverse TranscriptaseSouth AfricaHIV Envelope Protein gp120HIV ProteaseReceptors, HIVSubstance Abuse, IntravenousSexual PartnersPrevalenceMonitoring, PhysiologicHIV Long-Term SurvivorsCondomsUgandaAIDS-Related Opportunistic InfectionsUnsafe SexHealth Knowledge, Attitudes, PracticeZimbabweCross-Sectional StudiesRisk FactorsCoinfectionCounselingUnited StatesBlood Pressure MonitorsTime FactorsHIV EnteropathyProstitutionVoluntary ProgramsAfrica South of the SaharaHIV Envelope Protein gp41MalawiPopulation SurveillanceSafe SexAIDS Dementia ComplexEpidemicsCD4-Positive T-LymphocytesZambiaPregnancyCohort StudiesHeterosexualityMass ScreeningCircumcision, MaleMonitoring, AmbulatoryVirus ReplicationHIV Fusion InhibitorsHIV Wasting SyndromeQuestionnairesSyphilisPatient Acceptance of Health CareData DisplayHIV Integrase InhibitorsSocial StigmaStereotypingIndiaIncidenceSex WorkersHIV-2Drug Resistance, ViralHepatitis CProspective StudiesInterviews as TopicKenyaTuberculosisHIV SerosortingSocioeconomic FactorsHomosexualityTanzaniaSubstance-Related DisordersSentinel SurveillanceMolecular Sequence DataRural PopulationRisk Reduction BehaviorConsciousness MonitorsZidovudineCenters for Disease Control and Prevention (U.S.)Monitoring, IntraoperativeDrug UsersMedication AdherenceDeveloping CountriesHIV Integrase